SAN FRANCISCO -- Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of the use of neoadjuvant chemotherapy, according to updated ...
An existing oral drug already used to treat lung cancer could help improve survival rates for bladder cancer patients, a new clinical trial by UK scientists has found. There are approximately 10,300 ...
Add Yahoo as a preferred source to see more of our stories on Google. Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an ...
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
MedPage Today on MSN
FDA expands approval of chemo-free bladder cancer combo in curative setting
Perioperative Keytruda-Padcev for MIBC approved regardless of cisplatin eligibility ...
Stars Insider on MSN
Bladder cancer: The signs, symptoms, and treatments
Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...
A large electronic health record study suggests that difficulty recognizing painless blood in urine may delay diagnosis and worsen long-term survival for bladder cancer patients with color vision ...
Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...
Bladder cancer is one of the top 10 most common cancers globally, yet a widespread lack of awareness means it is frequently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results